ARVN
Arvinas Inc.
Company Overview
| Mkt Cap | $607.16M | Price | $10.14 |
| Volume | 2.23M | Change | +2.11% |
| P/E Ratio | -3.1 | Open | $9.99 |
| Revenue | $263.4M | Prev Close | $9.93 |
| Net Income | $-198.9M | 52W Range | $5.90 - $28.83 |
| Div Yield | N/A | Target | $12.13 |
| Overall | 71 | Value | 60 |
| Quality | -- | Technical | 83 |
No chart data available
Stock Overview
Updated DailyArvinas Inc. (ARVN) is a leading Healthcare company in the Biotechnology industry, currently trading at $10.14 with a market capitalization of $607.16 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ARVN with a volume of 2.23 million shares. The stock opened up 0.60% from yesterday's close of $9.93. Current analyst estimates project earnings of $-1.11 per share for this year, with next year targeting $-2.86.
ARVN demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ARVN include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 19.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 04:07 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARVN | $10.14 | +2.1% | 2.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |